Thanks, joelegs...actually, this is what I show the DEF14C to say:
The Company's Board of Directors approved this action on February 9, 2007 and recommended to effectuate a twenty for one (20:1) reverse split of the outstanding Common Stock, while retaining the current par value of $0.001, with appropriate adjustments to the capital accounts of Duska Therapeutics, with no stockholder to be reduced below one hundred (100) shares, on a per stockholder of record basis, and with all fractional shares rounded up.
I don't know if they changed that or not. Either way, you end up with at least 100 shares, which sure wouldn't be as good as 1000 shares. They may have upped it, if the OTCBB is right. Can't honestly say.
JJ
I am not a broker and profess to know nothing about trading stocks. Do your own DD. Buy, don't buy...sell, or don't sell at your own risk.
